29535798|t|Evaluation of Potential Mechanisms Controlling the Catalase Expression in Breast Cancer Cells.
29535798|a|Development of cancer cell resistance against prooxidant drugs limits its potential clinical use. MCF-7 breast cancer cells chronically exposed to ascorbate/menadione became resistant (Resox cells) by increasing mainly catalase activity. Since catalase appears as an anticancer target, the elucidation of mechanisms regulating its expression is an important issue. In MCF-7 and Resox cells, karyotype analysis showed that chromosome 11 is not altered compared to healthy mammary epithelial cells. The genomic gain of catalase locus observed in MCF-7 and Resox cells cannot explain the differential catalase expression. Since ROS cause DNA lesions, the activation of DNA damage signaling pathways may influence catalase expression. However, none of the related proteins (i.e., p53, ChK) was activated in Resox cells compared to MCF-7. The c-abl kinase may lead to catalase protein degradation via posttranslational modifications, but neither ubiquitination nor phosphorylation of catalase was detected after catalase immunoprecipitation. Catalase mRNA levels did not decrease after actinomycin D treatment in both cell lines. DNMT inhibitor (5-aza-2'-deoxycytidine) increased catalase protein level in MCF-7 and its resistance to prooxidant drugs. In line with our previous report, chromatin remodeling appears as the main regulator of catalase expression in breast cancer after chronic exposure to an oxidative stress.
29535798	51	59	Catalase	Gene	847
29535798	74	87	Breast Cancer	Disease	MESH:D001943
29535798	110	116	cancer	Disease	MESH:D009369
29535798	141	151	prooxidant	Chemical	MESH:D017382
29535798	193	198	MCF-7	CellLine	CVCL:0031
29535798	199	212	breast cancer	Disease	MESH:D001943
29535798	242	251	ascorbate	Chemical	MESH:D001205
29535798	252	261	menadione	Chemical	MESH:D024483
29535798	280	285	Resox	CellLine	
29535798	314	322	catalase	Gene	847
29535798	339	347	catalase	Gene	847
29535798	463	468	MCF-7	CellLine	CVCL:0031
29535798	473	478	Resox	CellLine	
29535798	517	530	chromosome 11	Chromosome	11
29535798	612	620	catalase	Gene	847
29535798	639	644	MCF-7	CellLine	CVCL:0031
29535798	649	654	Resox	CellLine	
29535798	693	701	catalase	Gene	847
29535798	720	723	ROS	Chemical	MESH:D017382
29535798	805	813	catalase	Gene	847
29535798	871	874	p53	Gene	7157
29535798	876	879	ChK	Gene	4145
29535798	898	903	Resox	CellLine	
29535798	922	927	MCF-7	CellLine	CVCL:0031
29535798	958	966	catalase	Gene	847
29535798	1074	1082	catalase	Gene	847
29535798	1102	1110	catalase	Gene	847
29535798	1132	1140	Catalase	Gene	847
29535798	1176	1189	actinomycin D	Chemical	MESH:D003609
29535798	1220	1224	DNMT	Gene	1786
29535798	1236	1258	5-aza-2'-deoxycytidine	Chemical	MESH:D000077209
29535798	1270	1278	catalase	Gene	847
29535798	1296	1301	MCF-7	CellLine	CVCL:0031
29535798	1324	1334	prooxidant	Chemical	MESH:D017382
29535798	1430	1438	catalase	Gene	847
29535798	1453	1466	breast cancer	Disease	MESH:D001943
29535798	Association	1786	847
29535798	Negative_Correlation	MESH:D000077209	1786
29535798	Positive_Correlation	MESH:D001205	847
29535798	Negative_Correlation	MESH:D001205	MESH:D001943
29535798	Negative_Correlation	MESH:D024483	MESH:D001943
29535798	Positive_Correlation	MESH:D000077209	847
29535798	Positive_Correlation	MESH:D024483	847
29535798	Association	MESH:D001943	847
29535798	Negative_Correlation	MESH:D017382	MESH:D009369

